IDEAYA Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,986	2,293	874	910	407	152
Market Cap Growth	-	162.34%	-3.94%	123.62%	166.90%	-
Enterprise Value	2,463	1,770	513	668	130	60
PE Ratio	-20.30	-20.30	-14.90	-18.29	-11.80	-3.63
PS Ratio	127.69	98.07	17.17	32.57	20.83	-
PB Ratio	4.81	3.69	2.50	3.02	2.05	1.52
P/FCF Ratio	-19.50	-19.50	-9.65	-15.58	7.40	-3.75
P/OCF Ratio	-19.90	-19.90	-10.03	-16.32	7.34	-3.88
EV/Sales Ratio	105.33	75.71	10.07	23.92	6.65	-
EV/EBITDA Ratio	-16.25	-16.25	-9.30	-14.30	-3.93	-1.48
EV/EBIT Ratio	-15.67	-15.67	-8.74	-13.43	-3.77	-1.43
EV/FCF Ratio	-15.06	-15.06	-5.66	-11.44	2.37	-1.48
Debt / Equity Ratio	0.00	0.00	0.01	0.02	0.03	0.07
Debt / EBITDA Ratio	-0.03	-0.03	-0.06	-0.11	-0.20	-0.17
Debt / FCF Ratio	-0.02	-0.02	-0.04	-0.09	0.12	-0.17
Quick Ratio	19.40	19.40	11.51	5.49	7.39	14.27
Current Ratio	19.65	19.65	11.68	5.56	7.47	14.65
Asset Turnover	0.05	0.05	0.14	0.08	0.09	0
Return on Equity (ROE)	-23.00%	-23.00%	-18.40%	-18.20%	-21.10%	-61.40%
Return on Assets (ROA)	-21.80%	-21.80%	-15.70%	-13.90%	-15.60%	-36.40%
Return on Capital (ROIC)	-21.54%	-21.54%	-17.71%	-16.39%	-17.24%	-41.31%
Earnings Yield	-3.78%	-4.93%	-6.71%	-5.47%	-8.48%	-27.53%
FCF Yield	-3.94%	-5.13%	-10.37%	-6.42%	13.51%	-26.67%
Buyback Yield / Dilution	-38.79%	-38.79%	-17.57%	-42.60%	-97.82%	-1206.87%
Total Shareholder Return	-38.79%	-38.79%	-17.57%	-42.60%	-97.82%	-1206.87%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).